The approval was supported by data from the 52-week, randomized, double-blind, multicenter, parallel-group, placebo-controlled, phase 3 trials BOREAS and NOTUS.
And if you're experiencing a chronic digestive condition like IBS, check with a healthcare provider about staying on top of your particular treatment plan ... particularly for older adults, children, ...